UnitedHealth Group Inc. has filed a prospectus with the Securities and Exchange Commission related to the issuance of new notes worth a total of $3 billion. The company agreed to sell four sets of notes, including 4.400% Notes due in 2028, 4.650% Notes due in 2031, 5.300% Notes due in 2035, and 5.950% Notes due in 2055. The issuance has been registered under the Securities Act of 1933, with the notes being issued pursuant to an Indenture agreement with U.S. Bank Trust Company. This move is part of UnitedHealth's broader financial strategy, and the related documents have been filed as exhibits to be incorporated into their automatic shelf registration statement.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. UnitedHealth Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-143717), on June 20, 2025, and is solely responsible for the information contained therein.